Showing results (201-210 of 221) with videos related to
Sort By:
Pageof 23
Immunity|August 12, 2022
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccinationYu Gao, Curtis Cai, David Wullimann, et al.Nature Immunology|September 22, 2023
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infectionMark M Painter, Timothy S Johnston, Kendall A Lundgreen, et al.Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.The Lancet. Infectious Diseases|March 30, 2020
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trialEsper G Kallas, Alexander Roberto Precioso, Ricardo Palacios, et al.Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.Science Immunology|November 10, 2022
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccinesJohn E Bowen, Young-Jun Park, Cameron Stewart, et al.Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.Journal of Virology|October 6, 2017
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in HumansAlba Grifoni, John Pham, John Sidney, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2021
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in ChileSusan M Bueno, Katia Abarca, Pablo A González, et al.Pageof 23